ArticleThe journal of allergy and clinical immunology. Global2026
Effect of once-daily ICS/LAMA/LABA triple therapy versus ICS/LABA on respiratory symptoms (E-RS: Asthma): Analysis of the phase IIIA CAPTAIN trial.
Emilio Pizzichini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.